3,4,5,6-tetrahydro-7-methoxy-6-(2-propenyl)-2H-azepine | 165385-44-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吖庚因类
• 英文名称: 3,4,5,6-tetrahydro-7-methoxy-6-(2-propenyl)-2H-azepine
• 英文别名: 7-methoxy-6-prop-2-enyl-3,4,5,6-tetrahydro-2H-azepine
• CAS: 165385-44-4
• 化学式: C₁₀H₁₇NO
• 分子量: 167.251
• InChiKey: FQSNRQYOHRPQCY-UHFFFAOYSA-N

物化性质

• 沸点：
  223.7±9.0 °C(Predicted)
• 密度：
  0.95±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  21.6
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3,4,5,6-tetrahydro-7-methoxy-6-(2-propenyl)-2H-azepine 在 氯化铵 作用下， 以 甲醇 为溶剂， 生成 hexahydro-3-(2-propenyl)-1H-azepin-2-imine, monohydrochloride
  参考文献：
  名称：

  2-Iminohomopiperidinium Salts as Selective Inhibitors of Inducible Nitric Oxide Synthase (iNOS)

  摘要：

  An attractive approach to the treatment of inflammatory conditions such as osteo-and rheumatoid arthritis, inflammatory bowel disease, and sepsis is through the selective inhibition of human inducible nitric oxide synthase (hiNOS) since localized excess nitric oxide (NO) release has been implicated in the pathology of these diseases. A series of monosubstituted iminohomopiperidinium salts possessing lipophilic functionality at ring positions 3, 5, 6, and 7 has been synthesized, and series members have demonstrated the ability to inhibit the hiNOS isoform with an IC50 as low as 160 nM (7). Compounds were found that selectively inhibit hiNOS over the human endothelial constitutive enzyme (heNOS) with a heNOS/hiNOS IC50 ratio in excess of 100 and as high as 314 (9). Potencies for inhibition of hiNOS and the human neuronal constitutive enzyme (hnNOS) are comparable. Substitution in the 3 and 7 positions provides compounds that exhibit the greatest degree of selectivity for hiNOS and hnNOS over heNOS. Submicromolar potencies for 6 and 7 in a mouse RAW cell assay demonstrated the ability of these compounds to inhibit iNOS in a cellular environment. These latter compounds were also found to be orally bioavailable and efficacious due to their ability to inhibit the increase in plasma nitrite/nitrate levels in a rat LPS model.

  DOI：

  10.1021/jm9704715
• 作为产物：
  描述：

  2-(2'-丙烯基)环己酮肟 在 sodium hydroxide 、 苯磺酰氯 作用下， 以 二氯甲烷 、 丙酮 为溶剂， 反应 60.0h， 生成 3,4,5,6-tetrahydro-7-methoxy-6-(2-propenyl)-2H-azepine
  参考文献：
  名称：

  2-Iminohomopiperidinium Salts as Selective Inhibitors of Inducible Nitric Oxide Synthase (iNOS)

  摘要：

  An attractive approach to the treatment of inflammatory conditions such as osteo-and rheumatoid arthritis, inflammatory bowel disease, and sepsis is through the selective inhibition of human inducible nitric oxide synthase (hiNOS) since localized excess nitric oxide (NO) release has been implicated in the pathology of these diseases. A series of monosubstituted iminohomopiperidinium salts possessing lipophilic functionality at ring positions 3, 5, 6, and 7 has been synthesized, and series members have demonstrated the ability to inhibit the hiNOS isoform with an IC50 as low as 160 nM (7). Compounds were found that selectively inhibit hiNOS over the human endothelial constitutive enzyme (heNOS) with a heNOS/hiNOS IC50 ratio in excess of 100 and as high as 314 (9). Potencies for inhibition of hiNOS and the human neuronal constitutive enzyme (hnNOS) are comparable. Substitution in the 3 and 7 positions provides compounds that exhibit the greatest degree of selectivity for hiNOS and hnNOS over heNOS. Submicromolar potencies for 6 and 7 in a mouse RAW cell assay demonstrated the ability of these compounds to inhibit iNOS in a cellular environment. These latter compounds were also found to be orally bioavailable and efficacious due to their ability to inhibit the increase in plasma nitrite/nitrate levels in a rat LPS model.

  DOI：

  10.1021/jm9704715

文献信息

• Amidino dervatives useful as nitric oxide synthase inhibitors
  申请人：G. D. Searle & Co.

  公开号：US05854234A1

  公开（公告）日：1998-12-29

  The current invention discloses useful pharmaceutical compositions containing azepine derivatives useful as nitric oxide synthase inhibitors.

  本发明公开了含有用作一氧化氮合酶抑制剂的氮杂环衍生物的有用药物组合物。
• Amidino derivatives useful as nitric oxide synthase inhibitors
  申请人：G.D. Searle & Co.

  公开号：US06046211A1

  公开（公告）日：2000-04-04

  The current invention discloses useful pharmaceutical compositions containing amidino derivative useful as nitric oxide synthase inhibitors.

  本发明公开了含有作为一氧化氮合酶抑制剂的有用酰胺基衍生物的有用药物组合物。
• An Aza-Enolate Alkylation Strategy for the Synthesis of α-Alkyl-δ-amino Esters and α-Alkyl Valerolactams
  作者：Steven Bull、Piers Taylor、Philip Andrews

  DOI：10.1055/s-2006-939726

  日期：2006.6

  Alkylation of the aza-enolate of valerolactim methyl ether with electrophiles affords α-alkyl lactims that may be hydro­lysed under mild acidic conditions to afford their corresponding α-alkyl-δ-amino esters as their hydrochloride salts. Neutralisation of these salts with base results in smooth intramolecular cyclisation to afford their corresponding α-alkyl lactams in excellent yield.

  缬草内脂甲醚的偶氮烯醇与亲电体发生烷基化反应，产生δ-烷基内酰胺，在弱酸性条件下进行水解，可得到相应的δ-烷基-δ-氨基酯盐酸盐。用碱中和这些盐后，可顺利进行分子内环化，从而以极好的收率得到相应的δ-烷基内酰胺。
• Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors
  申请人：G.D. Searle & Co.

  公开号：US06448286B1

  公开（公告）日：2002-09-10

  The current invention discloses useful pharmaceutical compositions containing amidino derivative useful as nitric oxide synthase inhibitors.

  当前发明揭示了有用的药物组合物，其中包含作为一氧化氮合酶抑制剂有用的氨基甲酰衍生物。
• AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS
  申请人：G.D. SEARLE & CO.

  公开号：EP0724570A1

  公开（公告）日：1996-08-07